Brief: Nanosonics Receives FDA De Novo Clearance For Coris
March 20 (Reuters) - Nanosonics Ltd NAN.AX: NANOSONICS RECEIVES FDA DE NOVO CLEARANCE FOR CORIS Further company coverage: NAN.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NANOSONICS
See all newsBrief: Nanosonics Announces Second FDA 510(K) Clearance For Coris System
Australia's Nanosonics hits 2-year low on forecast miss
Brief: Nanosonics Posts FY Net Income Attributable Of AUD 17.8 Million
Australia's Nanosonics set for worst day in over two months on weak interim profit
Morningstar sees Nanosonics' endoscope-cleaning device supporting recurring revenue